Page 88 - Revista Argentina de Transfusión 2-2019

22. DeBaun, M.R., Gordon, M., McKinstry, R.C., Noetzel, M.J., White, 36. Koshy M, Weiner SJ, Miller ST, et al. Surgery and anesthesia in
D.A., Sarnaik, S.A. et al Controlled trial of transfusions for si- sickle cell disease. Cooperative Study of Sickle Cell Diseases.
lent cerebral infarcts in sickle cell anemia. New England Jour- Blood 1995; 86(10): 3676-3684
nal of Medicine, (2014) 371, 699–710. 37. VichinskyEP,HaberkernCM,NeumayrL,etal.A comparison of con-
23. Howard, J., Malfroy, M., Llewelyn, C., Choo, L., Hodge, R., servative and aggressive transfusion regimens in
Johnson, T et al The Transfusion Alternatives Preoperatively in theperioperative management of sickle cell disease. N Engl J
Sickle Cell Disease (TAPS) study: a randomised, controlled, Med 1995;333: 206-13.
multicentre clinical trial. Lancet, (2013) 381, 930–938. 38. Al-Riyami AZ, Daar S Transfusion in Haemoglobinopathies: Re-
24. Kelly, S., Deng, X., Hoppe, C. & Styles, L. A pilot randomized trial view and recommendations for local blood banks and transfu-
of red blood cell transfusion for acute treatment of vaso-occlu- sion services in Oman. Sultan Qaboos Univ Med J. 2018
sive pain episodes in sickle cell anaemia. British Journal of Feb;18(1):e3-e12.
Haematology, (2015) 171, 288–290 39. Milkins, C., Berryman, J., Cantwell, C., Elliott, C., Haggas, R.,
25. Hulbert, M.L., Scothorn, D.J., Panepinto, J.A., Scott, J.P., Jones, J et al. for the British Committee for Standards in Hae-
Buchanan, G.R., Sarnaik, S. et al Exchange blood transfusion matology. Guidelines for pre-transfusion compatibility proce-
compared with simple transfusion for first overt stroke is as- dures in blood transfusion laboratories. Transfusion Medicine
sociated with a lower risk of subsequent stroke: a retrospec- (2013) (Oxford, England), 23,3 –35
tive cohort study of 137 children with sickle cell anemia. Jour- 40. Vichinsky, E.P. The prevention and management of
nal of Pediatrics, (2006) 149,710–712. alloimmunization in sickle cell disease:the benefit of extended
26. Malinowski AK, Shehata N, D’Souza R, Kuo KH, Ward R, Shah phenotypic matching of red blood cells. Immunohematology,
PS et al Prophylactic transfusion for pregnant women with (2012) 28, 20–23.
sickle cell disease: a systematic review and meta-analysis. 41. Kappler-Gratias, S., Auxerre, C., Dubeaux, I., Beolet, M., Ripaux,
Blood. 2015 Nov 19;126(21):2424-35 M., Le Pennec, P.Y. & Pham, B.N. Systematic RH genotyping and
27. Vichinsky EP, Neumayr LD, Earles AN, et al; National Acute variant identification in French donors of African origin. Blood
Chest Syndrome Study Group. Causes and outcomes of the Transfusion, (2014) 12, s264–s27
acute chest syndrome in sickle cell disease. N Engl J Med. 42. Yazdanbakhsh K, Ware RE, Noizat-Pirenne F Red blood cell
2000;342(25):1855-1865 alloimmunization in sickle cell disease: pathophysiology, risk
28. Jain S1, Bakshi N2, Krishnamurti L2 Acute Chest Syndrome in factors, and transfusion management Blood. 2012 Jul
Children with Sickle Cell DiseasePediatr Allergy Immunol 19;120(3):528-37.
Pulmonol. 2017 Dec 1;30(4):191-201. 43. Desai,P.C,Deal,A.M,Pfaff,E.R, Qaqish, B,Hebden, L.M, Park, Y.a
29. Saylors RL, Watkins B, Saccente S, Tang X. Comparison of et al. Alloimmunization is associated with older age of trans-
automated red cell exchange transfusion and simple transfu- fused red blood cells in sickle cell disease. American Journal
sion for the treatment of children with sickle cell disease acute Hematology(2015) 28,68-75
chest syndrome. Pediatr Blood Cancer. 2013;60(12):1952-1956. 44. Sippert,E.A, Visentainer, J.E.L, Alves, H.V et al. Red blood cell
30. Adams, R.J., McKie, V.C., Hsu, L., Files, B., Vichinsky, E., Pegelow, alloimmunization in patients with sickle cell disease: correla-
C. et al.Prevention of a first stroke by transfusions in children tion with HLA and cytokine gen polymorphisms.(2017) Transfu-
with sickle cell anemia and abnormal results on transcranial sion, 57.379-389
doppler ultrasonography. The New England Journal of Medi- 45. Vidler JB, Gardner K, Amenyah K, Mijovic A, Thein SL. Delayed
cine, (1998) 339,5 –11 haemolytic transfusion reaction in adults with sickle cell dis-
31. Adams, R.J. & Brambilla, DDiscontinuing prophylactic transfu- ease: a 5-year experience. Br J Haematol. 2015 Jun;169(5):746-
sions used to prevent stroke in sickle cell disease. New Eng- 53.
land Journal of Medicine, (2005) 353, 2769–2778. 46. Gardner K, Hoppe C, Mijovic A, Thein SL. How we treat delayed
32. Ware, R.E., Davis, B.R., Schultz, W.H., Brown, R.C., Aygun, B., haemolytic transfusion reactions in patients with sickle cell
Sarnaik, S.et al. Hydroxycarbamide versus chronic transfusion disease. Br J Haematol. 2015 Sep;170 (6):745-56.. Review
for maintenance of transcranial doppler flow velocities in chil- 47. Narbey D, Habibi A, Chadebech P, Mekontso-Dessap A, Khellaf
dren with sickle cell anaemia-TCD With Transfusions Changing M, Lelièvre JD, et al.Incidence and predictive score for delayed
to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, hemolytic transfusion reaction in adult patients with sickle
noninferiority trial. Lancet, (2016) 387, 661–670. cell disease. Am J Hematol. 2017 Dec;92(12):1340-1348.
33. Scothorn, D.J., Price, C., Schwartz, D., Terrill, C., Buchanan, G.R., 48. Wahl, S.K., Garcia, A., Hagar, W., Gildengorin, G., Quirolo, K. &
Shurney, Risk of recurrent stroke in children with sickle cell dis- Vichinsky, E. Lower alloimmunization rates in pediatric sickle
ease receiving blood transfusion therapy for at least 5 years cell patients on chronic erythrocyt apheresis compared to
after initial stroke. Journal of Pediatrics, (2002) 140,348–354. chronic simple transfusions. Transfusion, (2012)52, 2671–2676.
34. Ware, R.E., Helms, R.W. & Investigators, S.WStroke With Trans- 49. Howell C, Douglas K, Cho G, El-Ghariani K, Taylor P, Potok D, et
fusions Changing to Hydroxyurea (SWiTCH). Blood, (2012) 119, al. Guideline on the clinical use of apheresis procedures for the
3925– 3932. treatment of patients and collection of cellular therapy prod-
35. Steinberg, M.H., McCarthy, W.F., Castro, O., Ballas, S.K., ucts. British Committee for Standards in Haematology. Transfus
Armstrong, F.D., Smith, W..Investigators of the Multicenter Med. 2015 Apr;25(2):57-78.
Study of Hydroxyurea in Sickle Cell, A. & Follow-Up, M.S.H.P. 50. Weinstein,R.Basic principles of therapeutic blood exchange
The risks and benefits of long-term use of hydroxyurea in sickle In: Apheresis. Principles and practice 3rd edition269-294
cell anemia: a 17.5 year follow-up. American Journal of 51. Rachmilewitz EA, Giardina PJ. How I treat thalassemia. Blood.
Hematology, (2010) 85, 403–408. 2011 Sep 29;118(13):3479-88 Review

Pág. 172 AAHITC - Lavalleja 1214 (C1414DTZ) Vol. XLV / N° 2 / 2019 Dra. Calmet, Romina
Cdad. Aut. de Bs. As. - Argentina Págs. 149 / 173
Tel/Fax: (54-11)4771-2501 - L.Rot.
E-mail: aahitc@aahitc.org.ar